Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses.

Pickens JA, Tripp RA.

Viruses. 2018 Jan 21;10(1). pii: E48. doi: 10.3390/v10010048. Review.

2.

The nonstructural proteins of Pneumoviruses are remarkably distinct in substrate diversity and specificity.

Ribaudo M, Barik S.

Virol J. 2017 Nov 6;14(1):215. doi: 10.1186/s12985-017-0881-7.

3.

Interferon-λs: Front-Line Guardians of Immunity and Homeostasis in the Respiratory Tract.

Andreakos E, Salagianni M, Galani IE, Koltsida O.

Front Immunol. 2017 Sep 29;8:1232. doi: 10.3389/fimmu.2017.01232. eCollection 2017. Review.

4.

Distinct patterns of innate immune activation by clinical isolates of respiratory syncytial virus.

Levitz R, Gao Y, Dozmorov I, Song R, Wakeland EK, Kahn JS.

PLoS One. 2017 Sep 6;12(9):e0184318. doi: 10.1371/journal.pone.0184318. eCollection 2017.

5.

Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity.

Canedo-Marroquín G, Acevedo-Acevedo O, Rey-Jurado E, Saavedra JM, Lay MK, Bueno SM, Riedel CA, Kalergis AM.

Front Cell Infect Microbiol. 2017 Aug 16;7:367. doi: 10.3389/fcimb.2017.00367. eCollection 2017. Review.

6.

New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV.

Gálvez NMS, Soto JA, Kalergis AM.

Int J Mol Sci. 2017 Aug 11;18(8). pii: E1753. doi: 10.3390/ijms18081753. Review.

7.

Deep sequencing of RSV from an adult challenge study and from naturally infected infants reveals heterogeneous diversification dynamics.

Lau JW, Kim YI, Murphy R, Newman R, Yang X, Zody M, DeVincenzo J, Grad YH.

Virology. 2017 Oct;510:289-296. doi: 10.1016/j.virol.2017.07.017. Epub 2017 Aug 3.

8.

Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses.

Chatterjee S, Luthra P, Esaulova E, Agapov E, Yen BC, Borek DM, Edwards MR, Mittal A, Jordan DS, Ramanan P, Moore ML, Pappu RV, Holtzman MJ, Artyomov MN, Basler CF, Amarasinghe GK, Leung DW.

Nat Microbiol. 2017 Jun 30;2:17101. doi: 10.1038/nmicrobiol.2017.101.

9.

Interferon Lambda: Modulating Immunity in Infectious Diseases.

Syedbasha M, Egli A.

Front Immunol. 2017 Feb 28;8:119. doi: 10.3389/fimmu.2017.00119. eCollection 2017. Review.

10.

The interdependencies of viral load, the innate immune response, and clinical outcome in children presenting to the emergency department with respiratory syncytial virus-associated bronchiolitis.

Piedra FA, Mei M, Avadhanula V, Mehta R, Aideyan L, Garofalo RP, Piedra PA.

PLoS One. 2017 Mar 7;12(3):e0172953. doi: 10.1371/journal.pone.0172953. eCollection 2017.

11.

The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy.

Bruening J, Weigel B, Gerold G.

J Immunol Res. 2017;2017:7232361. doi: 10.1155/2017/7232361. Epub 2017 Feb 1. Review.

12.

Respiratory syncytial virus infection induces a subset of types I and III interferons in human dendritic cells.

Hillyer P, Mane VP, Chen A, Dos Santos MB, Schramm LM, Shepard RE, Luongo C, Le Nouën C, Huang L, Yan L, Buchholz UJ, Jubin RG, Collins PL, Rabin RL.

Virology. 2017 Apr;504:63-72. doi: 10.1016/j.virol.2017.01.017. Epub 2017 Jan 31.

13.

IFN-λ: A New Inducer of Local Immunity against Cancer and Infections.

Lasfar A, Zloza A, de la Torre A, Cohen-Solal KA.

Front Immunol. 2016 Dec 15;7:598. doi: 10.3389/fimmu.2016.00598. eCollection 2016. Review.

15.
16.

Influenza A viruses suppress cyclooxygenase-2 expression by affecting its mRNA stability.

Dudek SE, Nitzsche K, Ludwig S, Ehrhardt C.

Sci Rep. 2016 Jun 6;6:27275. doi: 10.1038/srep27275.

17.

Identification of Respiratory Syncytial Virus Nonstructural Protein 2 Residues Essential for Exploitation of the Host Ubiquitin System and Inhibition of Innate Immune Responses.

Whelan JN, Tran KC, van Rossum DB, Teng MN.

J Virol. 2016 Jun 24;90(14):6453-6463. doi: 10.1128/JVI.00423-16. Print 2016 Jul 15.

18.

Human metapneumovirus small hydrophobic (SH) protein downregulates type I IFN pathway signaling by affecting STAT1 expression and phosphorylation.

Hastings AK, Amato KR, Wen SC, Peterson LS, Williams JV.

Virology. 2016 Jul;494:248-56. doi: 10.1016/j.virol.2016.04.022. Epub 2016 Apr 27.

19.

ISG15 Is Upregulated in Respiratory Syncytial Virus Infection and Reduces Virus Growth through Protein ISGylation.

González-Sanz R, Mata M, Bermejo-Martín J, Álvarez A, Cortijo J, Melero JA, Martínez I.

J Virol. 2016 Jan 13;90(7):3428-38. doi: 10.1128/JVI.02695-15.

20.

Parainfluenza Virus 3 Blocks Antiviral Mediators Downstream of the Interferon Lambda Receptor by Modulating Stat1 Phosphorylation.

Eberle KC, McGill JL, Reinhardt TA, Sacco RE.

J Virol. 2015 Dec 30;90(6):2948-58. doi: 10.1128/JVI.02502-15.

Supplemental Content

Support Center